UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 181

Sortiert nach

Guidelines for Treatment of Candidiasis

Clinical infectious diseases, 2004-01, Vol.38 (2), p.161-189

2004

Link zum Volltext

Verfügbarkeit prüfen

International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections

Clinical Infectious Diseases, 1997-07, Vol.25 (1), p.43-59

1997

Link zum Volltext

Verfügbarkeit prüfen

Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America

Clinical infectious diseases, 2009-03, Vol.48 (5), p.503-535

2009

Link zum Volltext

Verfügbarkeit prüfen

Multicenter Clinical Evaluation of the (1→3) β-D-Glucan Assay as an Aid to Diagnosis of Fungal Infections in Humans

Clinical infectious diseases, 2005-09, Vol.41 (5), p.654-659

2005

Link zum Volltext

Verfügbarkeit prüfen

Combination antifungal therapy

Antimicrobial agents and chemotherapy, 2004-03, Vol.48 (3), p.693-715

2004

Link zum Volltext

Verfügbarkeit prüfen

β-d-Glucan as a Diagnostic Adjunct for Invasive Fungal Infections: Validation, Cutoff Development, and Performance in Patients with Acute Myelogenous Leukemia and Myelodysplastic Syndrome

Clinical infectious diseases, 2004-07, Vol.39 (2), p.199-205

2004

Link zum Volltext

Verfügbarkeit prüfen

Has Antifungal Susceptibility Testing Come of Age?

Clinical infectious diseases, 2002-10, Vol.35 (8), p.982-989

2002

Link zum Volltext

Verfügbarkeit prüfen

A Prospective Observational Study of Candidemia: Epidemiology, Therapy, and Influences on Mortality in Hospitalized Adult and Pediatric Patients

Clinical infectious diseases, 2003-09, Vol.37 (5), p.634-643

2003

Link zum Volltext

Verfügbarkeit prüfen

Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial

The Lancet (British edition), 2005-10, Vol.366 (9495), p.1435-1442

2005

Link zum Volltext

Verfügbarkeit prüfen

Amphotericin B: Time for a New “Gold Standard”

Clinical infectious diseases, 2003-08, Vol.37 (3), p.415-425

2003

Link zum Volltext

Verfügbarkeit prüfen

Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus

Clinical infectious diseases, 2002-01, Vol.34 (1), p.7-14

2002

Link zum Volltext

Verfügbarkeit prüfen

Determination of Fungicidal Activities against Yeasts and Molds: Lessons Learned from Bactericidal Testing and the Need for Standardization

Clinical Microbiology Reviews, 2004-04, Vol.17 (2), p.268-280

2004

Link zum Volltext

Verfügbarkeit prüfen

Antifungal Susceptibility Survey of 2,000 Bloodstream Candida Isolates in the United States

Antimicrobial Agents and Chemotherapy, 2003-10, Vol.47 (10), p.3149-3154

2003

Link zum Volltext

Verfügbarkeit prüfen

Correlation of MIC with Outcome for Candida Species Tested against Voriconazole: Analysis and Proposal for Interpretive Breakpoints

Journal of Clinical Microbiology, 2006-03, Vol.44 (3), p.819-826

2006

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Synergy of Caspofungin and Amphotericin B against Aspergillus and Fusarium spp

Antimicrobial Agents and Chemotherapy, 2002-01, Vol.46 (1), p.245-247

2002

Link zum Volltext

Verfügbarkeit prüfen

Practice Guidelines for the Treatment of Candidiasis

Clinical infectious diseases, 2000-04, Vol.30 (4), p.662-678

2000

Link zum Volltext

Verfügbarkeit prüfen

Correlation between E-Test, Disk Diffusion, and Microdilution Methods for Antifungal Susceptibility Testing of Fluconazole and Voriconazole

Antimicrobial Agents and Chemotherapy, 2003-05, Vol.47 (5), p.1647-1651

2003

Link zum Volltext

Verfügbarkeit prüfen

Rules for identifying patients at increased risk for candidal infections in the surgical intensive care unit: approach to developing practical criteria for systematic use in antifungal prophylaxis trials

Medical mycology (Oxford), 2005-05, Vol.43 (3), p.235-243

2005

Link zum Volltext

Verfügbarkeit prüfen

A Randomized and Blinded Multicenter Trial of High-Dose Fluconazole plus Placebo versus Fluconazole plus Amphotericin B as Therapy for Candidemia and Its Consequences in Nonneutropenic Subjects

Clinical infectious diseases, 2003-05, Vol.36 (10), p.1221-1228

2003

Link zum Volltext

Verfügbarkeit prüfen

Antifungal Susceptibility Testing: Practical Aspects and Current Challenges

Clinical Microbiology Reviews, 2001-10, Vol.14 (4), p.643-658

2001

Link zum Volltext

Verfügbarkeit prüfen

European expert opinion on the management of invasive candidiasis in adults

Clinical microbiology and infection, 2011-09, Vol.17, p.1-12

2011

Link zum Volltext

Verfügbarkeit prüfen

In vitro susceptibility testing methods for caspofungin against Aspergillus and fusarium isolates

Antimicrobial agents and chemotherapy, 2001, Vol.45 (1), p.327-330

2001

Link zum Volltext

Verfügbarkeit prüfen

International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemia

European journal of clinical microbiology & infectious diseases, 2005-10, Vol.24 (10), p.654-661

2005

Link zum Volltext

Verfügbarkeit prüfen

Fusariosis Associated with Pathogenic Fusarium Species Colonization of a Hospital Water System: A New Paradigm for the Epidemiology of Opportunistic Mold Infections

Clinical infectious diseases, 2001-12, Vol.33 (11), p.1871-1878

2001

Link zum Volltext

Verfügbarkeit prüfen

Pathogenic molds (includingAspergillusspecies) in hospital water distribution systems: a 3-year prospective study and clinical implications for patients with hematologic malignancies

Blood, 2003-04, Vol.101 (7), p.2542-2546

2003

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 181

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(170)
Mit Volltextzugriff
(151)

Publikationsform

Artikel
(180)
magazinearticle
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(176)
Life Sciences & Biomedicine
(171)
Humans
(120)
Biological And Medical Sciences
(100)
Microbiology
(97)
Medical Sciences
(89)
Infectious Diseases
(65)
Pharmacology. Drug Treatments
(54)
Antifungal Agents
(50)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(49)
Antifungal Agents - Pharmacology
(42)
Immunology
(41)
Male
(40)
Antifungal Agents - Therapeutic Use
(37)
Candida - Drug Effects
(35)
Female
(32)
Candida
(30)
Infections
(30)
Adult
(29)
Mycology
(29)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Guidelines for Treatment of Candidiasis

International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections

Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America

Multicenter Clinical Evaluation of the (1→3) β-D-Glucan Assay as an Aid to Diagnosis of Fungal Infections in Humans

Combination antifungal therapy

β-d-Glucan as a Diagnostic Adjunct for Invasive Fungal Infections: Validation, Cutoff Development, and Performance in Patients with Acute Myelogenous Leukemia and Myelodysplastic Syndrome

Has Antifungal Susceptibility Testing Come of Age?

A Prospective Observational Study of Candidemia: Epidemiology, Therapy, and Influences on Mortality in Hospitalized Adult and Pediatric Patients

Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial

Amphotericin B: Time for a New “Gold Standard”

Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus

Determination of Fungicidal Activities against Yeasts and Molds: Lessons Learned from Bactericidal Testing and the Need for Standardization

Antifungal Susceptibility Survey of 2,000 Bloodstream Candida Isolates in the United States

Correlation of MIC with Outcome for Candida Species Tested against Voriconazole: Analysis and Proposal for Interpretive Breakpoints

In Vitro Synergy of Caspofungin and Amphotericin B against Aspergillus and Fusarium spp

Practice Guidelines for the Treatment of Candidiasis

Correlation between E-Test, Disk Diffusion, and Microdilution Methods for Antifungal Susceptibility Testing of Fluconazole and Voriconazole

Rules for identifying patients at increased risk for candidal infections in the surgical intensive care unit: approach to developing practical criteria for systematic use in antifungal prophylaxis trials

A Randomized and Blinded Multicenter Trial of High-Dose Fluconazole plus Placebo versus Fluconazole plus Amphotericin B as Therapy for Candidemia and Its Consequences in Nonneutropenic Subjects

Antifungal Susceptibility Testing: Practical Aspects and Current Challenges

European expert opinion on the management of invasive candidiasis in adults

In vitro susceptibility testing methods for caspofungin against Aspergillus and fusarium isolates

International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemia

Fusariosis Associated with Pathogenic Fusarium Species Colonization of a Hospital Water System: A New Paradigm for the Epidemiology of Opportunistic Mold Infections

Pathogenic molds (includingAspergillusspecies) in hospital water distribution systems: a 3-year prospective study and clinical implications for patients with hematologic malignancies

Suchergebnisse filtern